Surgical Considerations in Advance Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, and Cutaneous Melanoma: a Head and Neck Perspective

被引:0
作者
Zhou T.C. [1 ]
Eskander A.E. [2 ]
Old M.O. [1 ,3 ]
Kang S.Y. [1 ,3 ]
Teknos T.N. [4 ,5 ]
机构
[1] Department of Otolaryngology – Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH
[2] Department of Otolaryngology – Head and Neck Surgery, University of Toronto, Toronto, ON
[3] Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
[4] Department of Otolaryngology – Head and Neck Surgery, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Lakeside 1071, Cleveland, 44106, OH
[5] Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland, OH
关键词
Basal cell carcinoma; Head and neck; Melanoma; Review; Squamous cell carcinoma; Surgery;
D O I
10.1007/s40136-018-0195-3
中图分类号
学科分类号
摘要
Purpose of Review: Skin cancers, including basal cell carcinoma, cutaneous squamous cell carcinoma, and cutaneous melanoma, are the most common cancer worldwide. The treatment of these cancers is primarily surgical, and when treated early and correctly, the prognosis is excellent. In this review, we aim to discuss the appropriate surgical management of skin cancers and associated controversies as it pertains to the head and neck. Recent Findings: Evidences guiding treatment have expanded enormously over the past decade. Studies have drastically improved our understanding of skin cancer including risk factors for tumor recurrence and metastasis, indicated margin size of surgical excision, the role of sentinel lymph node biopsy, and the management of occult and gross regional neck metastasis. Summary: Management of skin cancer poses a unique challenge in the head and neck region due to its proximity to anatomic sensitive areas and complex lymphatic drainage. Understanding how to efficiently manage the primary tumor site and the regional lymph nodes is paramount in minimizing locoregional recurrence and improving overall survival. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码:140 / 150
页数:10
相关论文
共 97 条
[11]  
Gooding C.A., White G., Yatsuhashi M., Significance of marginal extension in excised basal-cell carcinoma, N Engl J Med, 273, pp. 923-924, (1965)
[12]  
Liu F.F., Maki E., Warde P., Payne D., Fitzpatrick P., A management approach to incompletely excised basal cell carcinomas of skin, Int J Radiat Oncol Biol Phys, 20, pp. 423-428, (1991)
[13]  
Codazzi D., Van Der Velden J., Carminati M., Bruschi S., Bocchiotti M.A., Di Serio C., Et al., Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management, J Plast Surg Hand Surg, 48, pp. 38-43, (2014)
[14]  
Kumar P., Orton C.I., McWilliam L.J., Watson S., Incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit, Br J Plast Surg, 53, pp. 563-566, (2000)
[15]  
Rieger K.E., Linos E., Egbert B.M., Swetter S.M., Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer, J Cutan Pathol, 37, pp. 59-67, (2010)
[16]  
Pascal R.R., Hobby L.W., Lattes R., Crikelair G.F., Prognosis of “incompletely excised” versus “completely excised” basal cell carcinoma, Plast Reconstr Surg, 41, pp. 328-332, (1968)
[17]  
Masud D., Moustaki M., Staruch R., Dheansa B., Basal cell carcinomata: risk factors for incomplete excision and results of re-excision, J Plast Reconstr Aesthet Surg, 69, pp. 652-656, (2016)
[18]  
Wolf D.J., Zitelli J.A., Surgical margins for basal cell carcinoma, Arch Dermatol, 123, pp. 340-344, (1987)
[19]  
Bichakjian C., Armstrong A., Baum C., Bordeaux J.S., Brown M., Busam K.J., Et al., Guidelines of care for the management of basal cell carcinoma, J Am Acad Dermatol, S0190–9622, (2018)
[20]  
Porceddu S.V., Veness M.J., Guminski A., Nonmelanoma cutaneous head and neck cancer and Merkel cell carcinoma: current concepts, advances, and controversies, J Clin Oncol, 33, pp. 3338-3345, (2015)